VIRACEPT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, Inc.. The primary component is Nelfinavir Mesylate.
| Product ID | 55289-477_7bbfc667-bfa8-08c2-e053-2a91aa0a8009 |
| NDC | 55289-477 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VIRACEPT |
| Generic Name | Nelfinavir Mesylate |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 1997-03-14 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020779 |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | NELFINAVIR MESYLATE |
| Active Ingredient Strength | 250 mg/1 |
| Pharm Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2011-04-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020779 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-04-21 |
| Marketing End Date | 2019-09-12 |
| Ingredient | Strength |
|---|---|
| NELFINAVIR MESYLATE | 250 mg/1 |
| SPL SET ID: | 91152af4-a9c8-4b14-acbb-e4b6f2be145a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 52959-289 | VIRACEPT | nelfinavir mesylate |
| 53808-0809 | Viracept | NELFINAVIR MESYLATE |
| 55289-477 | VIRACEPT | nelfinavir mesylate |
| 63010-010 | VIRACEPT | nelfinavir mesylate |
| 63010-027 | VIRACEPT | nelfinavir mesylate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VIRACEPT 74683161 2007831 Live/Registered |
AGOURUN PHARMACEUTICALS, LLC 1995-06-01 |